Aditxt to terminate arrangement agreement with Appili Therapeutics

2 months ago 3

Healthcare

Aditxt (NASDAQ:ADTX) has decided to terminate the previously announced arrangement agreement with Appili Therapeutics
Management intends to formally notify Appili of the termination, effective May 31, 2025.
ADTX shares up 3.6% on Monday.
Source: Press release

More on Aditx Therapeutics

Recommended For You

More Trending News

Read Entire Article